Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2003.01401.x/fullpdf
Reference30 articles.
1. Guidelines in the management of Helicobacter pylori infection in Japan;Asaka;Helicobacter,2001
2. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori;Marshall;Lancet,1988
3. A multicenter, double-blind study on triple therapy with lansoprazole, amoxycillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients;Asaka;Helicobacter,2001
4. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy;Murakami;Int J Antimicrob Agents,2002
5. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy;Rinaldi;Aliment Pharmacol Ther,1999
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of metronidazole resistance on Helicobacter pylori eradication regimens;Journal of Digestive Diseases;2022-10
2. Second-line Therapy for Helicobacter Pylori Eradication: State of the Art;Mini-Reviews in Medicinal Chemistry;2022-10
3. Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL;Proceedings of the National Academy of Sciences;2021-04-14
4. Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?;Helicobacter;2019-04-16
5. Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients;Therapeutic Advances in Gastroenterology;2019-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3